In recent weeks, the board of directors at Metaplanet has found itself at the centre of a heated confrontation with a vocal coalition of shareholders who are demanding greater transparency and accountability over a highly contentious executive payout plan. The dispute revolves around a compensation package that was approved by the board but has been characterised by critics as overly generous, poorly justified, and potentially detrimental to the long‑term financial health of the company. While the independent directors have defended the decision by highlighting the inherent financial risks associated with the company’s ongoing restructuring efforts, they have also been careful to avoid providing detailed answers to two of the most pressing concerns raised by investors: the exact nature of the shares exercised by former chief executive officer Alex Gerovich and the involvement of the private‑equity vehicle known as MMXX Ventures. The controversy began when Metaplanet disclosed that a new executive remuneration framework would grant a substantial pool of stock options and cash bonuses to senior management, contingent on the achievement of specific performance milestones over the next three to five years.
According to the filing, the plan is intended to align the interests of the leadership team with those of the shareholders by incentivising value creation, cost‑saving initiatives, and successful execution of the company’s strategic pivot toward a more diversified product portfolio. However, many investors quickly pointed out that the projected milestones are based on optimistic assumptions about market growth and that the payout thresholds could be met even if the company merely maintains its current level of earnings, rather than delivering genuine incremental value. Shareholder activists have organised a series of meetings, circulated open letters, and even filed a formal proposal to amend the company’s compensation policy at the upcoming annual general meeting. Their argument centres on the principle that the board, particularly its independent members, has a fiduciary duty to safeguard shareholder wealth and to ensure that executive compensation is proportionate to actual performance.
They cite a series of comparable cases in the technology sector where overly aggressive payout schemes have resulted in shareholder backlash, depressed stock prices, and, in some instances, regulatory scrutiny. In response, the independent directors—who are legally required to act without influence from the company’s management—have issued a public statement emphasizing the extraordinary financial risk that Metaplanet has undertaken in the past twelve months. The company has been navigating a complex restructuring process that includes the divestiture of under‑performing business units, a significant reduction in headcount, and the renegotiation of several large supplier contracts. According to the directors, these actions have placed the firm in a precarious cash‑flow position, making it essential to retain top‑tier talent capable of steering the turnaround.
They argue that the compensation plan is a necessary tool to attract and keep executives who possess the expertise to manage the high‑stakes restructuring while delivering the strategic outcomes demanded by the board. Nevertheless, the directors have stopped short of addressing two specific queries that have dominated the shareholder discourse. First, there remains a lack of clarity about the exact number of shares that Alex Gerovich, the former CEO who stepped down earlier this year, exercised under the previous compensation arrangement before his departure. The original agreement allowed Gerovich to purchase a substantial block of Metaplanet stock at a discounted price, a provision that many investors believe could have resulted in a windfall for the former chief executive, especially if the stock price subsequently rose due to the restructuring efforts.
The board has acknowledged that Gerovich did exercise a portion of his options but has not disclosed the precise quantity or the timing of the transactions, citing confidentiality clauses and ongoing legal considerations. Second, the role of MMXX Ventures—a private‑equity firm that has historically been a major shareholder in Metaplanet—has not been fully explained. MMXX Ventures is known for its activist approach, often pushing portfolio companies toward aggressive cost‑cutting and strategic realignment.
Critics argue that the involvement of MMXX may have influenced the design of the payout plan to favour executives who are aligned with the firm’s short‑term value‑extraction objectives, rather than those focused on sustainable, long‑term growth. While the board has confirmed that MMXX holds a significant equity stake, it has not clarified whether the venture capital firm had any direct input into the compensation framework or whether any of its representatives sat on the compensation committee that drafted the plan.
The lack of detailed answers has only intensified shareholder frustration, leading some institutional investors to threaten a vote against the remuneration policy and to consider filing a derivative lawsuit alleging that the directors breached their fiduciary duties. Legal experts note that while directors are generally protected by the business judgment rule—provided they act in good faith and with reasonable care—the rule does not shield them from accountability if they withhold material information that could affect shareholders’ voting decisions.
From a broader perspective, the Metaplanet case exemplifies the delicate balance that boards must strike between rewarding leadership for navigating turbulent periods and maintaining the confidence of the investing public. In an environment where corporate governance standards are increasingly scrutinised, especially after high‑profile scandals in the tech industry, boards are expected to provide transparent rationales for compensation decisions, disclose any potential conflicts of interest, and ensure that remuneration structures are tightly linked to measurable performance outcomes. Looking ahead, the upcoming annual general meeting will serve as a litmus test for the board’s ability to retain the support of its shareholders. If the compensation proposal is rejected, Metaplanet may be forced to revisit its executive pay strategy, potentially scaling back the payout amounts or introducing more stringent performance criteria.
Conversely, if the proposal passes, the board will need to address the lingering concerns about Gerovich’s exercised shares and the influence of MMXX Ventures in order to prevent future disputes and to demonstrate a commitment to transparent governance. In conclusion, the Metaplanet directors have defended their stance by pointing to the substantial financial risk and restructuring responsibilities that the company currently faces. Yet, without full disclosure regarding the former CEO’s share transactions and the precise involvement of a powerful private‑equity stakeholder, many shareholders remain unconvinced that the executive payout plan is justified.
The outcome of this showdown will not only shape Metaplanet’s compensation policies but could also set a precedent for how boards across the industry handle executive remuneration amid periods of significant organisational change.